- Publication in Human Gene Therapy provides rationale for the use of microdystrophin expression levels as a surrogate endpoint reasonably likely to predict clinical benefit for AAV gene therapy ...

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

OneOncology has completed 25 unique oncology and hematology pathways, and all have been published inside the platform’s clinical decision support tool, according to a news release from OneOncology.

If we were to convene a panel of healthcare experts to choose a goal that holds the promise of being both achievable and influential at improving the value of healthcare, it may very well be the ...

Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise. Meanwhile, ...

Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026 King of Prussia, Pennsylvania–(Newsfile Corp. – December 23, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: ...

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...